This content requires a premium subscription.
Please log in or subscribe to continue.
FierceBiotech Radio
The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles
Released: Nov 24, 2015
Fierce editors discuss the long-awaited merger agreement between Pfizer and Allergan, Martin Shkreli's CEO double duty, and the whimpering conclusion of two hostile takeovers.
The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles
